Načítá se...
Cardiovascular Risk of Proton Pump Inhibitors
Proton pump inhibitors (PPIs) are effective agents for the treatment of gastroesophageal reflux (GERD). However, these drugs have not been approved for long-term use. Now sold over the counter, these agents are being used chronically for GERD without medical supervision. The long-term use of PPIs ma...
Uloženo v:
| Vydáno v: | Methodist Debakey Cardiovasc J |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
The Methodist Hospital Houston, Texas
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6822659/ https://ncbi.nlm.nih.gov/pubmed/31687101 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14797/mdcj-15-3-214 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|